Algo version: 0.98b
Tekla Life Sciences is listed at the NYSE Exchange
Tekla Life Sciences [HQL]
NYSE Sector: Financial Services Industry:Asset Management

Is Tekla Life Sciences stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Tekla Life Sciences pays dividends. Last time was Friday 10th of January 2025 where the investors holding the stock on Thursday 21st of November 2024 were paid $0.5 per share. Over the last 103 times between 1996 and 2024, Tekla Life Sciences has paid $44.9388 with an average of $0.44 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Tekla Life Sciences 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $17.09, you would have made a loss of $-2.79 per share or -16.33%

Yes, the average daily trading liquidity for Tekla Life Sciences is $70 478 thousand. You should therefore be able to get in and out of your positions relatively fast.

Tekla Life Sciences has no real debt, which is good in periods of high inflation. Tekla Life Sciences has a very good net profit margin of 122.69% and should have very high tolerances against inflation.

We have calculated the inflation risk for Tekla Life Sciences to be low [0.3 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.